Orcosa was founded by Vincent T. Mileto in 2020.

How much funding has Orcosa raised?

Orcosa has disclosed $56.5M raised across 3 rounds.

Where is Orcosa headquartered?

Orcosa is headquartered in Ewing, US.

Orcosa

Ewing, US · Founded 2020 · Delaware corporation

Find your way into Orcosa

77 people in our graph share verified history with the Orcosa team — schools, employers, funds. One of them is your warm intro.

Jay Fraserunlockedknows Vincent T. Mileto · together at Catalent (overlapped)

×9knows the team · via Catalent

×2knows the team · via Cardinal Health

Orcosa is a clinical-stage life-sciences company developing the Rapid Infusion Technology (RITe) platform, orally disintegrating tablets designed to improve drug absorption through the cheek tissue without water. The company controls formulation, development, and manufacturing in-house and is advancing a proprietary cannabinoid composition for the management of pain and inflammation.

Biotech Healthtech Medical Devices

Founders & leadership

Orcosa was founded in 2020 by Vincent T. Mileto.

Vincent T. Mileto Co-Founder & Chief Operating OfficerVincent T. Mileto is Co-Founder and Chief Operating Officer of Orcosa, a clinical-stage life-sciences company developing oral disintegrating tablet technology for drug delivery. He holds a Certified Pharmaceutical GMP Professional certification with the American Society for Quality and has experience in pharmaceutical operations and business development.

Robert M. PollaroExecutive Vice President and Chief Legal Officer

Bryan ` RidallExecutive

Mark RidallNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$56.5M disclosed across 3 rounds · 2021–2024

▶$7.3MraisedJan 2025 · 17 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Robert M. PollaroDirector, Executive Officer
Bryan RidallDirector, Executive Officer
Vincent MiletoDirector, Executive Officer

Offering amount: $15.5M
Amount sold: $7.3M
First sale: Dec 2024
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$11.3MraisedJan 2025 · 36 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Robert M. PollaroDirector, Executive Officer
Vincent MiletoDirector, Executive Officer
Bryan ` RidallDirector, Executive Officer

Offering amount: $11.3M
Amount sold: $11.3M
First sale: Sep 2021
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$37.9MraisedMar 2021 · 50 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Vincent MiletoExecutive Officer, Director
Bryan RidallDirector, Executive Officer
Mark RidallExecutive Officer, Director
Robert M. PollaroExecutive Officer, Director

Offering amount: $37.9M
Amount sold: $37.9M
First sale: Mar 2021
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

Doximity9 shared keywordsDoximity is the largest verified network of healthcare professionals in the U.S., connecting physicians, PAs, NPs, pharmacists, and medical students across specialties and care settings. The platform provides mobile-first tools for clinical communication, collaboration, and workflow optimization.

Practo8 shared keywordsPracto operates an online healthcare platform offering a directory of verified doctors, appointment booking at hospitals and clinics, online consultations across 20+ specialities, subscription health plans, diagnostic test collection, and medicine delivery. It also provides practice management and hospital information management software for clinics and hospitals.

Companies competing with Orcosa for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Ewing New Jersey based Orcosa is raising $3,529,800.00 in New Equity Investment. - intelligence360intelligence360.news · Nov 2021

Frequently asked questions

What does Orcosa do?: Orcosa is a clinical-stage life-sciences company developing the Rapid Infusion Technology (RITe) platform, orally disintegrating tablets designed to improve drug absorption through the cheek tissue without water. The company controls formulation, development, and manufacturing in-house and is advancing a proprietary cannabinoid composition for the management of pain and inflammation.
Who founded Orcosa?: Orcosa was founded by Vincent T. Mileto in 2020.
How much funding has Orcosa raised?: Orcosa has disclosed $56.5M raised across 3 rounds.
Where is Orcosa headquartered?: Orcosa is headquartered in Ewing, US.